D.E. Shaw & Co’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $468K | Sell |
8,454
-55,120
| -87% | -$2.62M | ﹤0.01% | 3883 |
|
|
2025
Q4 | $2.38M | Sell |
63,574
-31,098
| -33% | -$1.26M | ﹤0.01% | 2917 |
|
|
2025
Q3 | $3.83M | Buy |
94,672
+47,758
| +102% | +$1.58M | ﹤0.01% | 2452 |
|
|
2025
Q2 | $1.2M | Buy |
+46,914
| New | +$1.02M | ﹤0.01% | 3111 |
|
|
2025
Q1 | – | Sell |
-19,286
| Closed | -$405K | – | 4610 |
|
|
2024
Q4 | $405K | Sell |
19,286
-57,612
| -75% | -$1.33M | ﹤0.01% | 3742 |
|
|
2024
Q3 | $1.73M | Buy |
76,898
+13,837
| +22% | +$267K | ﹤0.01% | 2814 |
|
|
2024
Q2 | $1.06M | Buy |
63,061
+12,574
| +25% | +$202K | ﹤0.01% | 3169 |
|
|
2024
Q1 | $653K | Sell |
50,487
-5,138
| -9% | -$61.6K | ﹤0.01% | 3352 |
|
|
2023
Q4 | $644K | Buy |
55,625
+12,892
| +30% | +$145K | ﹤0.01% | 3393 |
|
|
2023
Q3 | $546K | Sell |
42,733
-5,884
| -12% | -$83.4K | ﹤0.01% | 3396 |
|
|
2023
Q2 | $666K | Buy |
48,617
+12,761
| +36% | +$183K | ﹤0.01% | 3295 |
|
|
2023
Q1 | $549K | Sell |
35,856
-13,806
| -28% | -$211K | ﹤0.01% | 3515 |
|
|
2022
Q4 | $666K | Buy |
49,662
+3,345
| +7% | +$44.9K | ﹤0.01% | 3698 |
|
|
2022
Q3 | $616K | Sell |
46,317
-63,321
| -58% | -$1.09M | ﹤0.01% | 3905 |
|
|
2022
Q2 | $2.1M | Sell |
109,638
-12,405
| -10% | -$235K | ﹤0.01% | 3021 |
|
|
2022
Q1 | $2.44M | Buy |
122,043
+49,593
| +68% | +$1M | ﹤0.01% | 3121 |
|
|
2021
Q4 | $1.48M | Buy |
72,450
+7,952
| +12% | +$170K | ﹤0.01% | 3617 |
|
|
2021
Q3 | $1.39M | Buy |
64,498
+9,542
| +17% | +$230K | ﹤0.01% | 3344 |
|
|
2021
Q2 | $1.59M | Sell |
54,956
-27,340
| -33% | -$739K | ﹤0.01% | 3160 |
|
|
2021
Q1 | $2.01M | Sell |
82,296
-21,709
| -21% | -$490K | ﹤0.01% | 2579 |
|
|
2020
Q4 | $2.02M | Buy |
104,005
+23,568
| +29% | +$434K | ﹤0.01% | 2547 |
|
|
2020
Q3 | $1.4M | Buy |
80,437
+16,732
| +26% | +$357K | ﹤0.01% | 2636 |
|
|
2020
Q2 | $1.67M | Sell |
63,705
-59,544
| -48% | -$1.48M | ﹤0.01% | 2548 |
|
|
2020
Q1 | $2.98M | Buy |
123,249
+44,621
| +57% | +$1.09M | ﹤0.01% | 1863 |
|
|
2019
Q4 | $1.95M | Buy |
78,628
+50,339
| +178% | +$1.17M | ﹤0.01% | 2496 |
|
|
2019
Q3 | $603K | Sell |
28,289
-24,036
| -46% | -$658K | ﹤0.01% | 3119 |
|
|
2019
Q2 | $1.66M | Sell |
52,325
-78,599
| -60% | -$2.46M | ﹤0.01% | 2360 |
|
|
2019
Q1 | $4.32M | Buy |
130,924
+71,160
| +119% | +$2.21M | 0.01% | 1636 |
|
|
2018
Q4 | $1.92M | Buy |
59,764
+20,630
| +53% | +$778K | ﹤0.01% | 2183 |
|
|
2018
Q3 | $1.68M | Buy |
39,134
+17,421
| +80% | +$823K | ﹤0.01% | 2325 |
|
|
2018
Q2 | $1M | Sell |
21,713
-11,051
| -34% | -$489K | ﹤0.01% | 2703 |
|
|
2018
Q1 | $1.3M | Sell |
32,764
-10,100
| -24% | -$374K | ﹤0.01% | 2322 |
|
|
2017
Q4 | $1.44M | Buy |
42,864
+33,317
| +349% | +$1.18M | ﹤0.01% | 2363 |
|
|
2017
Q3 | $354K | Sell |
9,547
-916
| -9% | -$34.4K | ﹤0.01% | 3078 |
|
|
2017
Q2 | $388K | Sell |
10,463
-4,535
| -30% | -$148K | ﹤0.01% | 2923 |
|
|
2017
Q1 | $421K | Sell |
14,998
-16,906
| -53% | -$477K | ﹤0.01% | 2812 |
|
|
2016
Q4 | $935K | Buy |
31,904
+168
| +0.5% | +$4.58K | ﹤0.01% | 2500 |
|
|
2016
Q3 | $863K | Buy |
+31,736
| New | +$718K | ﹤0.01% | 2481 |
|
|
2016
Q2 | – | Sell |
-8,796
| Closed | -$238K | – | 3477 |
|
|
2016
Q1 | $238K | Sell |
8,796
-4,884
| -36% | -$140K | ﹤0.01% | 3120 |
|
|
2015
Q4 | $412K | Sell |
13,680
-43,773
| -76% | -$1.4M | ﹤0.01% | 3189 |
|
|
2015
Q3 | $1.82M | Sell |
57,453
-14,016
| -20% | -$512K | ﹤0.01% | 2173 |
|
|
2015
Q2 | $2.78M | Sell |
71,469
-26,899
| -27% | -$928K | ﹤0.01% | 1934 |
|
|
2015
Q1 | $3.48M | Sell |
98,368
-230,851
| -70% | -$7.43M | 0.01% | 1628 |
|
|
2014
Q4 | $10.4M | Sell |
329,219
-236,040
| -42% | -$6.53M | 0.01% | 1085 |
|
|
2014
Q3 | $12.7M | Buy |
565,259
+59,548
| +12% | +$1.19M | 0.02% | 938 |
|
|
2014
Q2 | $11.1M | Buy |
+505,711
| New | +$9.61M | 0.02% | 1027 |
|
Other funds holding PAHC
VCM
VPM
N
D.E. Shaw & Co's PAHC Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Phibro Animal Health (PAHC) stake by 87% in Q1 2026, selling an estimated $2.62M and leaving 8,454 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #3883.
D.E. Shaw & Co first reported a position in PAHC in Q2 2014 and has held it in 46 quarters since. The position peaked at $12.7M in Q3 2014. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- D.E. Shaw & Co held 8,454 shares of Phibro Animal Health worth $468K as of Q1 2026.
- D.E. Shaw & Co sold 55,120 Phibro Animal Health shares in Q1 2026, an estimated $2.62M.
- Phibro Animal Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3883 holding.
- D.E. Shaw & Co first reported a position in Phibro Animal Health in Q2 2014 and has held it in 46 quarters since.
- D.E. Shaw & Co's Phibro Animal Health position peaked at $12.7M in Q3 2014.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.